(Q43800942)

26 November 2017

title

Antinociceptive effect of the novel compound OT-7100 in a diabetic neuropathy model (English)

1 reference

26 November 2017

1 reference

S Miki

1

1 reference

26 November 2017

N Yoshinaga

2

1 reference

26 November 2017

T Iwamoto

3

1 reference

26 November 2017

T Yasuda

4

1 reference

26 November 2017

S Sato

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

European Journal of Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

430

1 reference

26 November 2017

issue

2-3

1 reference

26 November 2017

page(s)

229-234

1 reference

Mechanical hyperalgesia in streptozotocin-diabetic rats

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Prevention and treatment of the complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Anticonvulsant drugs for management of pain: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Serial in vivo determinations of nerve conduction velocity in rat tails. Physiological and pathological changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Gabapentin adjunctive therapy in neuropathic pain states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

7 January 2021

Diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimid ine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Ethical guidelines for investigations of experimental pain in conscious animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

Peripheral diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901373-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01373-5

1 reference

26 November 2017

1 reference